Dopamine D2 Occupancy as a Biomarker for Antipsychotics: Quantifying the Relationship with Efficacy and Extrapyramidal Symptoms

Journal Title: The AAPS Journal - Year 2011, Vol 13, Issue 1

Abstract

The online version of this article (doi:10.1208/s12248-010-9247-4) contains supplementary material, which is available to authorized users.

Authors and Affiliations

Rik de Greef, Alan Maloney, Per Olsson-Gisleskog, Joep Schoemaker, John Panagides

Keywords

Related Articles

Opioid ligands with mixed μ/δ opioid receptor interactions: An emerging approach to novel analgesics

Opioids are widely used in the treatment of severe pain. The clinical use of the opioids is limited by serious side effects such as respiratory depression, constipation, development of tolerance, and physical dependence...

Recommended reading in population pharmacokinetic pharmacodynamics

Developing the skills or expertise to create useful population pharmacokinetic-pharmacodynamic models can be a daunting task-the level of mathematical and statistical complexity is such that newcomers to the field are fr...

Pharmacokinetics of the time-dependent elimination of all-trans-retinoic acid in rats

The time-dependent elimination kinetics of all-transretinoic acid (ATRA) has been associated with autoinduction of its metabolism and has led to the hypothesis that rapid development of acquired clinical resistance to AT...

Cannabinoids, electrophysiology, and retrograde messengers: Challenges for the next 5 years

Most of the behavioral effects of cannabis and its active ingredients, the cannabinoids (Δ9THC being the most abundant of these), appear to be mediated by cannabinoid receptors. Endogenous cannabinoids (endocanna...

The Use of Betaine HCl to Enhance Dasatinib Absorption in Healthy Volunteers with Rabeprazole-Induced Hypochlorhydria

Many orally administered, small-molecule, targeted anticancer drugs, such as dasatinib, exhibit pH-dependent solubility and reduced drug exposure when given with acid-reducing agents. We previously demonstrated that beta...

Download PDF file
  • EP ID EP681292
  • DOI  10.1208/s12248-010-9247-4
  • Views 83
  • Downloads 0

How To Cite

Rik de Greef, Alan Maloney, Per Olsson-Gisleskog, Joep Schoemaker, John Panagides (2011). Dopamine D2 Occupancy as a Biomarker for Antipsychotics: Quantifying the Relationship with Efficacy and Extrapyramidal Symptoms. The AAPS Journal, 13(1), -. https://europub.co.uk/articles/-A-681292